Skip to main content
. 2014 Feb 4;77(3):618–624. doi: 10.1021/np400889x

Figure 1.

Figure 1

Small-molecule HIV-1 latency-reversing agents with known modes of action: protein kinase C activation (PKCa), histone deacetylase inhibition (HDACi), and histone methytransferase inhibition (HMTi).

HHS Vulnerability Disclosure